(Q48158796)

9 February 2018

title

Drug firms, the codification of diagnostic categories, and bias in clinical guidelines (English)

1 reference

9 February 2018

1 reference

Lisa Cosgrove

1

1 reference

9 February 2018

Emily E Wheeler

series ordinal

2

1 reference

9 February 2018

publication date

1 January 2013

1 reference

9 February 2018

Journal of Law, Medicine, and Ethics

published in

1 reference

9 February 2018

volume

41

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

644-653

1 reference

9 February 2018

DSM-III and the transformation of American psychiatry: a history

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Selling sickness: the pharmaceutical industry and disease mongering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Is premenstrual dysphoric disorder a distinct clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Diagnostic inflation: causes and a suggested cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Medical practice guidelines as malpractice safe harbors: illusion or deceit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Conflicts of interest, institutional corruption, and pharma: an agenda for reform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

A social science perspective on gifts to physicians from industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Prohibiting or 'managing' conflict of interest? A review of policies and procedures in three European drug regulation agencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

The American Psychiatric Association's guideline for major depressive disorder: a commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

When Sunlight Fails to Disinfect: Understanding the Perverse Effects of Disclosing Conflicts of Interest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Dynamic informed consent processes vital for treatment with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12074

21 January 2018

Identifiers

DOI

10.1111/JLME.12074

1 reference

9 February 2018

1 reference

9 February 2018